Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.

Davies, Jennifer C; Midgley, Angela; Carlsson, Emil; Donohue, Sean; Bruce, Ian N; Beresford, Michael W; Hedrich, Christian M

Davies, Jennifer C; Midgley, Angela; Carlsson, Emil; Donohue, Sean; Bruce, Ian N; Beresford, Michael W; Hedrich, Christian M.

Afiliación

Davies JC; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK christian.hedrich@liverpool.ac.uk.
Midgley A; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Carlsson E; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Donohue S; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Bruce IN; Arc Epidemiology Unit, University of Manchester, Manchester, UK.
Beresford MW; Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Hedrich CM; Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

RMD Open ; 6(2)2020 07.

Article en En | MEDLINE | ID: mdl-32723832

Asunto(s)

Biomarcadores; Calgranulina A/metabolismo; Calgranulina B/metabolismo; Nefritis Lúpica/diagnóstico; Nefritis Lúpica/metabolismo; Proteína S100A12/metabolismo; Adulto; Antirreumáticos/administración & dosificación; Antirreumáticos/efectos adversos; Antirreumáticos/uso terapéutico; Biomarcadores/sangre; Biomarcadores/orina; Calgranulina B/sangre; Calgranulina B/orina; Femenino; Humanos; Lupus Eritematoso Sistémico/sangre; Lupus Eritematoso Sistémico/complicaciones; Lupus Eritematoso Sistémico/etiología; Nefritis Lúpica/tratamiento farmacológico; Masculino; Persona de Mediana Edad; Pronóstico; Rituximab/administración & dosificación; Rituximab/efectos adversos; Rituximab/uso terapéutico; Proteína S100A12/sangre; Proteína S100A12/orina; Índice de Severidad de la Enfermedad

Palabras clave

Arthritis; Cytokines; Inflammation; Juvenile; Lupus Erythematosus; Psoriatic; Systemic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Biomarcadores / Calgranulina A / Calgranulina B / Proteína S100A12 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: RMD Open Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google